Welcome to
World Mitochondria Society
Congress & Workshop 2021


On behalf of the Scientific Committee of the World Mitochondria Society (WMS) we are excited to announce the 12th Conference on Targeting Mitochondria 2021. The meeting will be a hybrid conference: in person and virtually. We have confidence that by this time the pandemic will be under control and easy traveling will again be possible.

Targeting Mitochondria 2021 Agenda

Mitochondria logo

During three days, many oral and poster communications will be presented and will cover:

  • Recent Advances on Mitochondrial Dysfunctions and Dynamics in Chronic Diseases
  • Mitochondria Dysfunction in COVID-19 pathogenesis
  • Mitochondria and Strategic Role in Intracellular Communication : Targeting mtDNA–Containing Exosomes
  • The Challenge of Qualitative and Quantitative Assessment of  Mitochondrial Function in vitro and in vivo
  • Strategies to Target Mitochondria: Clinical Trials and Potential Mitochondria-based Therapies


WMS Challenges in the Acceleration of Mitochondrial Medicine


Submit your innovation and technology for review by WMS Scientific Committee. Top ranked Innovations will be offered an opportunity to showcase your technology to all World Mitochondria Society Members.

Submit your innovation before August 30, 2021.

Online Workshop - How to Evaluate Mitochondria Function ?

How-to-Evaluate-Mitochondria-Function v1

The aim of this workshop is to discuss the last advances in mitochondria assessment and evaluation. The workshop will be interactive and will be recorded.
if you wish to have a short talk during the workshop, please contact us.


Targeting Mitochondria 2021 Speakers

Targeting Mitochondria 2021-Volkmar-Weissig Introduction Note
Volkmar Weissig
, President of the World Mitochondria Society, Midwestern University, USA

Mitochondrial DNA in cancer: The overlooked oncogenomeMitochondrial DNA in cancer: The overlooked oncogenome
Payam A. Gammage, CRUK Beatson Institute, United Kingdom
targeting mitochondria 2021 Dr. Claire McCoyMitochondrial arginase-2 is essentialfor IL-10 metabolic reprogrammingof inflammatory macrophages
Claire McCoy, Royal College of Surgeons in Ireland, Ireland 
Glucose Metabolism Control of T Cell ImmunityGlucose Metabolism Control of T Cell Immunity
Ming Li, Immunology Program, Memorial Sloan Kettering Cancer Center, USA

Targeting Mitochondria 2021 Stephen-P. Chelko-v1Exercise-induced, mitochondrial-mediated cell death in Arrhythmogenic Cardiomyopathy
Stephen Chelko, Florida State University, USA

Patient-specific brain organoids for modeling mitochondrial diseasesPatient-specific brain organoids for modeling mitochondrial diseases
Alessandro Prigione, Heinrich Heine University (HHU), Germany

A Mitochondria-targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease PatientsA Mitochondria-targeted Caffeic Acid Derivative Reverts Cellular and Mitochondrial Defects in Human Skin Fibroblasts from Male Sporadic Parkinson’s Disease Patients
Paulo J. Oliveira, University of Coimbra, Portugal

Access to the Targeting Mitochondria 2020 Congress Platform



The Targeting Mitochondria 2020 Congress was held successfully on October 28-30, 2020 as virtual congress. During the congress, more than 78 Communications (Majors, Shorts and Posters). If you wish to access all recorded presentations with a list of attendees, questions, and answers sent to speakers, you can register here.